Skip to main content

Find Clinical Trials

Home
Conditions
Scleroderma, Systemic

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

433 public trials 124 recruiting studies

Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Recruiting

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

NCT07047690

Conditions: Connective Tissue Diseases, Lung Diseases, Lung Diseases, Interstitial, +7 more
Locations: Galderma Investigational Site # 8743 Ann Arbor, Michigan, United States

Galderma Investigational Site#7096 Arlington, Texas, United States

Galderma Investigational Site # 6213 Sankt Gallen, Switzerland

View Trial Details

Recruiting

TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis

NCT04380831

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

NCT03844061

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: Hospital for Special Surgery New York, United States

View Trial Details

Recruiting

Open Label Treprostinil Raynaud's Study

NCT07112183

Conditions: Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +12 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

NCT06822881

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations: Beijing GoBroad Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

NCT06548607

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arthritis, +31 more
Locations: The Third the People's Hospital of Bengbu Bengbu, Anhui, China

View Trial Details

Recruiting

Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.

NCT06947473

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +16 more
Locations: Beijing GoBroad Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

NCT07104721

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +35 more
Locations: The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

View Trial Details

Recruiting

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

NCT07246096

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +20 more
Locations: Changhai Hospital Shanghai, China

View Trial Details

Recruiting

Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images

NCT07228429

Conditions: Calcinosis, Calcinosis Cutis, Calcium Metabolism Disorders, +7 more
Locations: Yale Scleroderma Program New Haven, Connecticut, United States

View Trial Details